View on Pubmed.gov 23698299 | View on doi.org 10.1128/JVI.010...
Induction of cross-reactive antibodies to novel H7N9 influenza virus by recombinant Newcastle disease virus expressing a North American lineage H7 subtype hemagglutinin.
- Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Abstract
Severe human disease caused by the emerging H7N9 influenza virus in China warrants a rapid response. Here, we present a recombinant Newcastle disease virus expressing a North American lineage H7 influenza virus hemagglutinin. Sera from immunized mice were cross-reactive to a broad range of H7 subtype viruses and inhibited hemagglutination by the novel H7 hemagglutinin. Immunized mice were protected against a heterologous H7 subtype challenge, and genetic analysis suggested that cross-protective antibodies recognize conserved antigenic sites.
References
Lancet. 2004 Feb 21;363(9409):587-93
Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1356-61
CMAJ. 2007 Jan 2;176(1):47-53
J Virol. 2007 Oct;81(19):10558-66
Cited by 51 citations (total)
Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.
Newcastle Disease Virus-Vectored H7 and H5 Live Vaccines Protect Chickens from Challenge with H7N9 or H5N1 Avian Influenza Viruses.
Electronic publication date September 1, 2015
Qinfang Liu [...] Juergen A Richt et al.
Sporadic human infections by a novel H7N9 virus occurred over a large geographic region in China. In this study, we...
Journal Article Research Support, N.I.H., Extramural
Human antibody recognition of H7N9 influenza virus HA following natural infection.
Electronic publication date March 16, 2022
Iuliia M Gilchuk [...] James E Crowe et al.
Avian H7N9 influenza viruses cause sporadic outbreaks of human infections and threaten to cause a major pandemic. The breadth of...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
- •
- •
Substances
- •
- •
- •
- •